文献速递心脏核医学

对心肌灌注显像在急性胸痛管理中当前作用的批判性评价

Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.
PubMed 文献 · Semin Nucl Med · 2023-09-16

本文回顾了核心脏病学技术在急性冠脉综合征中的演变:从20世纪70年代焦磷酸盐显像和抗肌凝蛋白抗体辅助诊断急性心肌梗死,到80年代中期99mTc标记灌注示踪剂与SPECT用于评估溶栓和早期血运重建疗效及心肌 Salvage,再到当前快速成像和固态探测器专用心脏SPECT用于快速确认或排除急性冠脉综合征。

要点

  • 20世纪70年代心电图无法诊断且心肌酶评估尚处早期时,焦磷酸盐显像和抗肌凝蛋白抗体对急性心肌梗死诊断有重要价值。
  • 这些方法存在局限,在80年代末至90年代初溶栓治疗及直接和补救性PCI引入后被放弃。
  • 当前灌注SPECT用快速成像和固态探测器专用心脏SPECT,可快速确认或排除急性冠脉综合征,尤其适用于冠脉疾病低至中等可能且CCTA有绝对或相对禁忌时。

核心结论

  • 当前灌注SPECT,尤其使用快速成像技术和固态探测器专用心脏SPECT,允许快速确认或排除急性冠脉综合征,特别在冠状动脉疾病低至中等可能性时,尤其当存在冠状动脉计算机断层血管造影(CCTA)的绝对或相对禁忌证时。

研究设计与样本

  • 本文为综述,描述核心脏病学技术在急性冠脉综合征背景下的演变。

主要发现

  • 自20世纪70年代以来,当心电图未能提供诊断且心脏酶评估处于非常早期阶段时,核心脏病学对急性心肌梗死的病理生理和诊断贡献是根本性的。
  • 当时焦磷酸盐闪烁显像和抗肌凝蛋白抗体在确保诊断精确性方面作用重要,但这些方法显示局限性,并在80年代末和90年代初溶栓治疗及直接和补救性经皮冠状动脉介入(PCI)引入时被放弃。
  • 自80年代中期开始,99mTc标记化合物等灌注示踪剂的引入和广泛使用以及SPECT等技术进步,允许评估溶栓和早期血运重建的疗效,并深入评估心肌 Salvage。

临床怎么用

  • 当前灌注SPECT,尤其使用快速成像技术和固态探测器专用心脏SPECT,允许快速确认或排除急性冠脉综合征,特别在冠状动脉疾病低至中等可能性时,尤其当存在CCTA的绝对或相对禁忌证时。

局限性

  • 焦磷酸盐闪烁显像和抗肌凝蛋白抗体方法显示局限性,并在80年代末和90年代初被放弃。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This paper describes the evolution of nuclear cardiology techniques in the setting of acute coronary syndromes. Since the 1970s, the contribution of nuclear cardiology has been fundamental in delineating the physiopathology and diagnosis of acute myocardial infarction, when electrocardiogram (ECG) did not provide the diagnosis and when cardiac enzyme assessments were at a very early stage. In this clinical situation, at that time the role of pyrophosphate scintigraphy and antimyosin antibodies was important in ensuring diagnostic precision. However, these methods showed limitations and were abandoned in the late 80s and early 90s when therapeutic applications such as thrombolytic therapy, and primary-and rescue-percutaneous coronary intervention (PCI) were introduced. Beginning in the mid-80s, the introduction and widespread use of perfusion tracers such as 99mTc labelled compounds and technological advances such as SPECT, allowed to assess the efficacy of thrombolysis and early revascularization, as well as to assess in depth myocardial salvage. Currently, perfusion SPECT, especially using fast imaging techniques and dedicated cardiac SPECT with solid-state detectors, allows a quick confirmation or exclusion of acute coronary syndromes, particularly in low-to-intermediate likelihood of coronary artery disease (CAD), especially when there are absolute or relative contraindications to the use of coronary computed tomographic angiography (CCTA).

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Giubbini R, Paghera B, Dondi M, et al. Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain. Semin Nucl Med. 2023. PMID: 37722928. doi:10.1053/j.semnuclmed.2023.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。